{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:38:35Z","timestamp":1785382715813,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.taap.2020.115039","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:03:15Z","timestamp":1589198595000},"page":"115039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms"],"prefix":"10.1016","volume":"399","author":[{"given":"Supratim","family":"Choudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115039_bb0005","doi-asserted-by":"crossref","first-page":"17159","DOI":"10.1074\/jbc.274.24.17159","article-title":"Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1","volume":"274","author":"Abe","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2020.115039_bb0010","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2020.115039_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030855","article-title":"Regulation of organic anion transporting polypeptides (OATP) 1B1- and OATP1B3-mediated transport: an updated review in the context of OATP-mediated drug-drug interactions","volume":"19","author":"Alam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2020.115039_bb0020","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/gim.2014.41","article-title":"Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review","volume":"16","author":"Canestaro","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.taap.2020.115039_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0014-5793(00)01596-9","article-title":"Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liverspecific transporter-1 (rlst-1) in rat liver","volume":"474","author":"Cattori","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2020.115039_bb0030","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1124\/dmd.108.020594","article-title":"Utility of a novel oatp1b2 knockout mouse model for evaluating the role of oatp1b2 in the hepatic uptake of model compounds","volume":"36","author":"Chen","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2020.115039_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.2000.3105","article-title":"Cloning of the full-length coding sequence of rat liver-specific organic anion transporter-1 (rlst-1) and a splice variant and partial characterization of the rat lst-1 gene","volume":"274","author":"Choudhuri","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2020.115039_bb0040","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.xphs.2017.04.007","article-title":"Identification of endogenous biomarkers to predict the propensity of drug candidates to cause hepatic or renal transporter-mediated drug-drug interactions","volume":"106","author":"Chu","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2020.115039_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep.23984","article-title":"Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice","volume":"53","author":"Csanaky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2020.115039_bb0050","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2020.115039_bb0055","article-title":"A human-like bile acid pool induced by deletion of cyp2c70 modulates effects of farnesoid x receptor activation in mice","volume":"10","author":"de Boer","year":"2019","journal-title":"J. Lipid Res. Sep"},{"key":"10.1016\/j.taap.2020.115039_bb0060","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/mp200629s","article-title":"Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity","volume":"9","author":"DeGorter","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2020.115039_bb0065","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1177\/0091270011422815","article-title":"Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2\u2212\/\u2212 mice and intraindividual variability in human subjects","volume":"52","author":"DeGorter","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2020.115039_bb0070","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.28797","article-title":"In vivo disposition of doxorubicin is affected by mouse Oatp1a\/1b and human OATP1A\/1B transporters","volume":"135","author":"Durmus","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2020.115039_bb0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1515\/hsz-2018-0379","article-title":"Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1","volume":"400","author":"Fan","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.taap.2020.115039_bb0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/cpt.1224","article-title":"The international transporter consortium: summarizing advances in the role of transporters in drug development","volume":"104","author":"Giacomini","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2020.115039_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.taap.2020.115039_bb0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/dmd.113.054783","article-title":"Utility of Oatp1a\/1b-knockout and OATP1B1\/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein","volume":"42","author":"Higgins","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2020.115039_bb0095","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterol."},{"key":"10.1016\/j.taap.2020.115039_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulations of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2020.115039_bb0105","doi-asserted-by":"crossref","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","article-title":"A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters","volume":"274","author":"Hsiang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2020.115039_bb0110","first-page":"C795","article-title":"Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain","volume":"292","author":"Huber","year":"2007","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.taap.2020.115039_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fct.2015.06.006","article-title":"Okadaic acid is taken-up into the cells mediated by human hepatocytes transporter OATP1B3","volume":"83","author":"Ikema","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2020.115039_bb0120","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1053\/gast.2001.28704","article-title":"Hepatic uptake of cholecystokinin octapeptide by organic anion-transporting polypeptides OATP4 and OATP8 of rat and human liver","volume":"121","author":"Ismair","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2020.115039_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.28970","article-title":"Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel","volume":"136","author":"Iusuf","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2020.115039_bb0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.91.1.133","article-title":"Expression cloning of a rat liver Na(+)-independent organic anion transporter","volume":"91","author":"Jacquemin","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.taap.2020.115039_bb0135","article-title":"Hepatotoxicity induced by Sophora flavescens and hepatic accumulation of kurarinone, a major hepatotoxic constituent of Sophora flavescens in rats","volume":"22","author":"Jiang","year":"2017"},{"key":"10.1016\/j.taap.2020.115039_bb0140","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0016-5085(99)70333-1","article-title":"Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1","volume":"117","author":"Kakyo","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2020.115039_bb0145","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2020.115039_bb0150","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (oatps): influence of protein expression on drug\u2212drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2020.115039_bb0155","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2014.02.010","article-title":"A clinician\u2019s guide to statin drug-drug interactions","volume":"8","author":"Kellick","year":"2014","journal-title":"J. Clin.Lipidol."},{"key":"10.1016\/j.taap.2020.115039_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCRESAHA.109.203596","article-title":"Human skeletal muscle drug transporters determine local exposure and toxicity of statins","volume":"106","author":"Knauer","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2020.115039_bb2000","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/gast.2001.21176","article-title":"Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver","volume":"120","author":"Kullak-Ublick","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.taap.2020.115039_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/toxsci\/kfn038","article-title":"Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake\/toxicity of phalloidin and microcystin-LR","volume":"103","author":"Lu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2020.115039_bb0170","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1038\/srep17253","article-title":"SLCO1B1 variants and angiotensin converting enzyme inhibitor (Enalapril) -induced cough: a Pharmacogenetic study","volume":"5","author":"Luo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2020.115039_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1248\/bpb.b14-00767","article-title":"Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs","volume":"38","author":"Maeda","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2020.115039_bb0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/mol.118.114934","article-title":"OATP1B3-1B7 (LST-3TM12) is a drug transporter that affects endoplasmic reticulum access and the metabolism of ezetimibe","volume":"96","author":"Malagnino","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115039_bb0185","doi-asserted-by":"crossref","first-page":"G751","DOI":"10.1152\/ajpgi.00330.2018","article-title":"OATP1B3-1B7 a novel organic anion transporting polypeptide is modulated by FXR ligands and transports bile acids","volume":"317","author":"Malagnino","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.taap.2020.115039_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00498254.2019.1629043","article-title":"Genetic polymorphisms of human hepatic OATPs: functional consequences and effect on drug pharmacokinetics","volume":"50","author":"Nie","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2020.115039_bb0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2020.115039_bb0200","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(03)00060-2","article-title":"Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics","volume":"73","author":"Nishizato","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2020.115039_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/bbrc.2000.2830","article-title":"Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1)","volume":"272","author":"Ogura","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2020.115039_bb0210","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.xphs.2018.02.010","article-title":"Inhibition of organic anion transporting polypeptide 1B1 and 1B3 by betulinic acid: effects of preincubation and albumin in the media","volume":"107","author":"Oh","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2020.115039_bb0215","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1053\/j.gastro.2018.07.031","article-title":"Solute carrier organic anion transporter family member 3A1 is a bile acid efflux transporter in cholestasis","volume":"155","author":"Pan","year":"2018","journal-title":"Gastroenterol."},{"key":"10.1016\/j.taap.2020.115039_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2017.00047","article-title":"Cholecystokinin- from local gut hormone to ubiquitous messenger","volume":"8","author":"Rehfeld","year":"2017","journal-title":"Front. Endocrinol (Lausanne)"},{"key":"10.1016\/j.taap.2020.115039_bb0225","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2020.115039_bb0230","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2174\/13816128113199990463","article-title":"Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?","volume":"20","author":"Sanchez-Covarrubias","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2020.115039_bb0235","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.taap.2020.115039_bb0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.116.232066","article-title":"Coproporphyrins I and III as functional markers of OATP1B activity: in vitro and in vivo evaluation in preclinical species","volume":"357","author":"Shen","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2020.115039_bb0245","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1124\/dmd.118.081125","article-title":"Further studies to support the use of Coproporphyrin I and III as novel clinical biomarkers for evaluating the potential for organic anion transporting polypeptide 1B1 and OATP1B3 inhibition","volume":"46","author":"Shen","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2020.115039_bb0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2133\/dmpk.DMPK-10-RV-094","article-title":"Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions","volume":"26","author":"Shitara","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2020.115039_bb0255","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clpt.2004.03.010","article-title":"Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine","volume":"76","author":"Simonson","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2020.115039_bb0260","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2020.115039_bb0265","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4161\/cbt.4.8.1867","article-title":"Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel","volume":"4","author":"Smith","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.taap.2020.115039_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169719","article-title":"Preference of conjugated bile acids over unconjugated bile acids as substrates for OATP1B1 and OATP1B3","volume":"12","author":"Suga","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115039_bb0275","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s11095-017-2184-5","article-title":"Investigation of glycochenodeoxycholate sulfate and chenodeoxycholate glucuronide as surrogate endogenous probes for drug interaction studies of OATP1B1 and OATP1B3 in healthy japanese volunteers","volume":"34","author":"Takehara","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2020.115039_bb0280","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2020.115039_bb0285","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/FPC.0000000000000148","article-title":"SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acid","volume":"25","author":"Tornio","year":"2015","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.taap.2020.115039_bb0290","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2020.115039_bb0295","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1172\/JCI59526","article-title":"Complete OATP1B1 and OATP1B3 deficiency causes human rotor syndrome by interrupting conjugated bilirubin reuptake into the liver","volume":"122","author":"van de Steeg","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2020.115039_bb0300","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1078-0432.CCR-12-2080","article-title":"Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice","volume":"19","author":"van de Steeg","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2020.115039_bb0305","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/mol.108.046458","article-title":"Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2\/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin","volume":"74","author":"Zaher","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115039_bb0310","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfs123","article-title":"Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury","volume":"127","author":"Zhang","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2020.115039_bb0315","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bcp.2013.05.020","article-title":"Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism","volume":"86","author":"Zhang","year":"2013","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:50:07Z","timestamp":1758574207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":64,"alternative-id":["S0041008X20301630"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115039","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115039"}}